Sorafenib Completed Phase 1 Trials for Prostate Cancer / Colorectal Cancers / Mesothelioma / Sarcomas / Lung Cancers / Breast Cancer / Malignant Neoplasm of Pancreas / Head and Neck Carcinoma Treatment